Persistent URL of this record https://hdl.handle.net/1887/3276572
Documents
-
- Download
- 168685416_publishedVersion_None
- Publisher's Version
- open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)
- All authors
- Casali, P.G.; Cesne, A. le; Velasco, A.P.; Kotasek, D.; Rutkowski, P.; Hohenberger, P.; Fumagalli, E.; Judson, I.R.; Italiano, A.; Gelderblom, H.; Penel, N.; Hartmann, J.T.; Duffaud, F.; Goldstein, D.; Martin-Broto, J.; Gronchi, A.; Wardelmann, E.; Marreaud, S.; Zalcberg, J.R.; Litiere, S.; Blay, J.Y.
- Date
- 2021-04-01
- Title of host publication
- Annals of Oncology
- Volume
- 32
- Issue
- 4
- Pages
- 533 - 541